While pyrazinoic acid plays a beneficial role in the treatment of tuberculosis, it is also associated with certain toxicological effects. The primary concern is its contribution to hepatotoxicity, a common side effect observed with pyrazinamide therapy. Hepatotoxicity can range from mild liver enzyme elevation to severe liver injury, necessitating careful monitoring of liver function in patients undergoing treatment.
